Method for treating post-traumatic stress disorder
US10987350B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Inventors
Key dates
| Filing date | Apr 25, 2018 |
| Grant date | Apr 27, 2021 |
| Priority date | — |
| Expiry date | Apr 25, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed and described is a novel dose titration procedure for administering the opioid antagonist, nalmefene, to a patient diagnosed with post-traumatic stress disorder (PTSD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.